title: What can be expected from antimicrobial de-escalation in the critically ill?
authors.affiliation: Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8052, St. Louis, MO, 63110, USA, mkollef@dom.wustl.edu.
authors.forename: Marin H
authors.initials: MH
authors.lastname: Kollef
mesh_terms: D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000592:standards / Q000627:therapeutic use; D016638:Critical Illness / Q000628:therapy*; D020000:Decision Support Systems, Clinical; D004352:Drug Resistance, Microbial; D006801:Humans; D007362:Intensive Care Units; D008826:Microbial Sensitivity Tests
chemical_list: D000890:Anti-Infective Agents